SHALBY LIMITED (SHALBY) financials
SHALBY LIMITED (SHALBY) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]The company is the global lead…
- Market Cap: ₹1,393Cr.
- Current Price: ₹129
- Stock P/E: 12.3
- ROE: 9.08%
- ROCE: 9.67%
- Book Value: ₹115
- Dividend Yield: 0.00%
- 52W High / Low: ₹255/126
In Jun 2026, SHALBY LIMITED (SHALBY) reported sales ₹254 Cr and net profit ₹25 Cr.
Annual TTM: sales ₹916 Cr, net profit ₹112 Cr.
Shareholding: Promoters 74.33% (Sep 2026), FIIs 4.65% (Sep 2026), DIIs 0.31% (Sep 2026), Public 20.08% (Sep 2026), Others 0.62% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 221 | 207 | 237 | 224 | 214 | 225 | 254 |
| Expenses | 177 | 178 | 176 | 190 | 185 | 186 | 193 | 211 |
| Operating Profit | 35 | 43 | 31 | 47 | 39 | 28 | 31 | 42 |
| OPM % | 17% | 19% | 15% | 20% | 17% | 13% | 14% | 17% |
| Other Income | 5 | 6 | 7 | 6 | 6 | 8 | 5 | 5 |
| Interest | 3 | 3 | 3 | 3 | 4 | 4 | 2 | 3 |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 |
| Profit before tax | 28 | 36 | 26 | 40 | 31 | 22 | 23 | 34 |
| Tax % | 39% | 42% | 42% | 36% | 35% | 37% | -129% | 26% |
| Net Profit | 17 | 21 | 15 | 26 | 20 | 14 | 54 | 25 |
| EPS in Rs | 1.61 | 1.93 | 1.39 | 2.38 | 1.83 | 1.28 | 4.97 | 2.32 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 484 | 419 | 647 | 708 | 830 | 869 | 899 | 916 |
| Expenses | 401 | 331 | 516 | 565 | 651 | 712 | 752 | 775 |
| Operating Profit | 83 | 88 | 131 | 143 | 179 | 157 | 146 | 141 |
| OPM % | 17% | 21% | 20% | 20% | 22% | 18% | 16% | 15% |
| Other Income | 18 | 9 | 9 | 20 | 21 | 30 | 24 | 23 |
| Interest | 7 | 4 | 4 | 4 | 4 | 13 | 14 | 13 |
| Depreciation | 36 | 37 | 36 | 37 | 37 | 39 | 40 | 41 |
| Profit before tax | 57 | 55 | 100 | 121 | 158 | 136 | 116 | 110 |
| Tax % | 51% | 23% | 30% | 33% | 34% | 38% | 3% | — |
| Net Profit | 28 | 43 | 70 | 81 | 104 | 84 | 113 | 112 |
| EPS in Rs | 2.59 | 3.97 | 6.46 | 7.48 | 9.61 | 7.76 | 10.45 | 10.40 |
| Dividend Payout % | 19% | 25% | 15% | 16% | 12% | 0% | 0% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 108 | 108 | 108 | 108 | 107 | 107 | 107 | 108 |
| Reserves | 686 | 706 | 742 | 799 | 863 | 955 | 1,027 | 1,139 |
| Borrowings | 71 | 62 | 44 | 41 | 34 | 121 | 110 | 131 |
| Other Liabilities | 91 | 105 | 119 | 139 | 163 | 192 | 226 | 217 |
| Total Liabilities | 956 | 981 | 1,012 | 1,087 | 1,167 | 1,376 | 1,470 | 1,595 |
| Fixed Assets | 689 | 670 | 658 | 628 | 603 | 599 | 579 | 621 |
| CWIP | 3 | 6 | 8 | 6 | 10 | 5 | 8 | 0 |
| Investments | 24 | 43 | 32 | 62 | 313 | 511 | 599 | 623 |
| Other Assets | 239 | 262 | 315 | 391 | 242 | 260 | 284 | 350 |
| Total Assets | 956 | 981 | 1,012 | 1,087 | 1,167 | 1,376 | 1,470 | 1,595 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 46 | 57 | 77 | 101 | 165 | 140 | 149 | 91 |
| Cash from Investing Activity | -0 | -32 | -52 | -40 | -172 | -206 | -101 | -109 |
| Cash from Financing Activity | -51 | -22 | -28 | -17 | -38 | 72 | -36 | 9 |
| Net Cash Flow | -6 | 3 | -2 | 43 | -46 | 6 | 12 | -8 |
| Free Cash Flow | 14 | 37 | 56 | 93 | 162 | 110 | 126 | 18 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 67% | 93% | 98% | 94% | 134% | 89% | 102% | 88% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.27% | 74.27% | 74.27% | 74.33% | 74.33% | 74.33% | 74.33% | 74.33% |
| FIIs | 4.65% | 4.54% | 5.21% | 4.63% | 4.47% | 4.36% | 4.47% | 4.65% |
| DIIs | 0.14% | 0.18% | 0.19% | 0.19% | 0.19% | 0.25% | 0.30% | 0.31% |
| Public | 20.26% | 20.33% | 19.65% | 20.18% | 20.36% | 20.41% | 20.26% | 20.08% |
| Others | 0.69% | 0.69% | 0.69% | 0.66% | 0.66% | 0.66% | 0.65% | 0.62% |
| No. of Shareholders | 52,328 | 52,895 | 53,437 | 53,784 | 52,495 | 51,415 | 50,770 | 50,572 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 69 | 81 | 53 | 46 | 52 | 55 | 73 |
| Inventory Days | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 64 | 69 | 81 | 53 | 46 | 52 | 55 | 73 |
| Working Capital Days | 61 | 73 | 80 | 73 | 35 | 38 | 37 | 58 |
| ROCE % | 7% | 7% | 7% | 12% | 13% | 14% | 12% | 10% |
Shalby Limited
₹1,393Cr.
₹129
₹255/126
12.3
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of SHALBY LIMITED (SHALBY)?
The reported market capitalisation for SHALBY LIMITED (SHALBY) is ₹1,393Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of SHALBY?
The current price shown for SHALBY LIMITED (SHALBY) on Fincrux is ₹129 with a 52-week high/low of ₹255/126.
What is the P/E ratio of SHALBY LIMITED (SHALBY)?
The stock P/E for SHALBY LIMITED (SHALBY) is 12.3 on Fincrux, with ROE at 9.08% and ROCE at 9.67%.
What were SHALBY latest quarterly results?
For Jun 2026, SHALBY LIMITED (SHALBY) reported sales ₹254 Cr and net profit ₹25 Cr (figures in ₹ crore unless noted).
What are SHALBY annual sales and net profit?
For TTM, SHALBY LIMITED (SHALBY) shows sales of ₹916 Cr and net profit of ₹112 Cr on the Fincrux profit & loss statement.
Who owns SHALBY LIMITED (SHALBY)?
Latest shareholding for SHALBY LIMITED (SHALBY) on Fincrux: Promoters 74.33% (Sep 2026), FIIs 4.65% (Sep 2026), DIIs 0.31% (Sep 2026), Public 20.08% (Sep 2026), Others 0.62% (Sep 2026).
Where can I find SHALBY LIMITED (SHALBY) financials?
SHALBY LIMITED (SHALBY) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show SHALBY balance sheet and cash flow?
Yes. The SHALBY LIMITED (SHALBY) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.